A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells
Recognition and elimination of tumor cells by the immune system is crucial for limiting tumor growth. Natural killer (NK) cells become activated when the receptor NKG2D is engaged by ligands that are frequently upregulated in primary tumors and on cancer cell lines. However, the molecular mechanisms...
Main Authors: | Benjamin G Gowen, Bryan Chim, Caleb D Marceau, Trever T Greene, Patrick Burr, Jeanmarie R Gonzalez, Charles R Hesser, Peter A Dietzen, Teal Russell, Alexandre Iannello, Laurent Coscoy, Charles L Sentman, Jan E Carette, Stefan A Muljo, David H Raulet |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2015-11-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/08474 |
Similar Items
-
Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing
by: Elisabetta Vulpis, et al.
Published: (2023-05-01) -
In vitro Natural Killer cell immunotherapy for medulloblastoma
by: Lucia eFernandez, et al.
Published: (2013-04-01) -
Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis
by: Guo-Tian Ruan, et al.
Published: (2022-02-01) -
ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome
by: Nicholas J. W. Easom, et al.
Published: (2020-06-01) -
A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression
by: Trever T Greene, et al.
Published: (2016-11-01)